rs143494120
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_003640.5(ELP1):c.154A>G(p.Lys52Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_003640.5 missense
Scores
Clinical Significance
Conservation
Publications
- primary dysautonomiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health
- Riley-Day syndromeInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
- medulloblastomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ELP1 | NM_003640.5 | c.154A>G | p.Lys52Glu | missense_variant | Exon 3 of 37 | ENST00000374647.10 | NP_003631.2 | |
| ELP1 | XM_047423991.1 | c.154A>G | p.Lys52Glu | missense_variant | Exon 3 of 25 | XP_047279947.1 | ||
| ELP1 | NM_001318360.2 | c.-189A>G | 5_prime_UTR_variant | Exon 3 of 37 | NP_001305289.1 | |||
| ELP1 | NM_001330749.2 | c.-706A>G | 5_prime_UTR_variant | Exon 3 of 35 | NP_001317678.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ELP1 | ENST00000374647.10 | c.154A>G | p.Lys52Glu | missense_variant | Exon 3 of 37 | 1 | NM_003640.5 | ENSP00000363779.5 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152228Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000995 AC: 25AN: 251320 AF XY: 0.000103 show subpopulations
GnomAD4 exome AF: 0.0000486 AC: 71AN: 1461226Hom.: 0 Cov.: 31 AF XY: 0.0000440 AC XY: 32AN XY: 726932 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152228Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74378 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.K52E variant (also known as c.154A>G), located in coding exon 2 of the IKBKAP gene, results from an A to G substitution at nucleotide position 154. The lysine at codon 52 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Familial dysautonomia Uncertain:1
- -
not provided Uncertain:1
This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 52 of the ELP1 protein (p.Lys52Glu). This variant is present in population databases (rs143494120, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 455955). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at